Skip to menu Skip to content Skip to footer
Dr Sam Hollingworth
Dr

Sam Hollingworth

Email: 

Overview

Background

I am an academic and consultant working in global health with a focus on health technology assessment (HTA), health systems and services research, and the use of medicines in populations. I have a particular interest in the use of data and research for evidence-informed decision making and implementation science in the context of low and middle income countries, especially in sub-Saharan Africa. I have worked on international health projects in Indonesia and am currently working on several projects in HTA and medicines use in Ghana and sub-Saharan Africa. I work with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in general practice, cancer, psychiatry, neurology, and internal medicine. I have honorary or visiting appointments at the University of Queensland (UQ, Brisbane, Australia), Imperial College London (UK, International Decision Support Initiative) and Kwame Nkrumah University of Science and Technology (KNUST, Kumasi, Ghana). I have a BSc(Hons) and MPH from UQ and a PhD from Monash University. I have lived or worked in Australia (Brisbane, Melbourne), Canada (Toronto), Indonesia (Yogyakarta), UK (London), and Ghana (Accra, Kumasi). I worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). I am an experienced teacher having coordinated courses, lectured, and tutored in undergraduate and postgraduate programs. I was a Foundation Coordinator in the UQ Master of Pharmaceutical Industry Practice (from 2019). I am an advisor on diverse PhD and student research projects.

Availability

Dr Sam Hollingworth is:
Not available for supervision
Media expert

Qualifications

  • Bachelor (Honours) of Science (Advanced), The University of Queensland
  • Doctor of Philosophy, Monash University
  • Masters (Coursework) of Public Health, The University of Queensland

Research interests

  • Health technology assessment (HTA) and decision-making

    Working with partners in low and middle income countries to manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably

  • Economic evaluations within health care and evidence-based practice

    Critically appraising the quality of evidence and ‘value for money’ of medicines and health services

  • Use of medicines in populations (pharmacoepidemiology)

    Exploring the use of medicines and their side effects using routinely collected data and describing the ‘real world’ effectiveness of medicines (e.g. in cancer)

  • Health systems, services, and medicines in non-communicable diseases

    Describing the use of medicines and other health services to treat non-communicable diseases (NCDs) with a focus on low and middle income countries

Works

Search Professor Sam Hollingworth’s works on UQ eSpace

212 works between 1988 and 2024

61 - 80 of 212 works

2019

Journal Article

How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

Chun, Ka Lai Joyce, Olsen, Anna, Taing, Meng-Wong, Clavarino, Alexandra, Hollingworth, Samantha, Dwyer, Robyn, Middleton, Melissa and Nielsen, Suzanne (2019). How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities. Research in Social and Administrative Pharmacy, 15 (8), 1014-1020. doi: 10.1016/j.sapharm.2019.03.003

How prepared are pharmacists to provide over-the-counter naloxone? The role of previous education and new training opportunities

2019

Journal Article

Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country

Khanal, Saval, Veerman, Lennert, Nissen, Lisa and Hollingworth, Samantha (2019). Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country. Journal of Pharmaceutical Health Services Research, 10 (1), 91-99. doi: 10.1111/jphs.12265

Forecasting the amount and cost of medicine to treat type 2 diabetes mellitus in Nepal using knowledge on medicine usage from a developed country

2019

Journal Article

Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life

Johnson, Stephanie R., Carter, Hannah E., Leo, Paul, Hollingworth, Samantha A., Davis, Elizabeth A., Jones, Timothy W., Conwell, Louise S., Harris, Mark, Brown, Matthew A., Graves, Nicholas and Duncan, Emma L. (2019). Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life. Diabetes Care, 42 (1), 69-76. doi: 10.2337/dc18-0261

Cost-effectiveness analysis of routine screening using massively parallel sequencing for maturity-onset diabetes of the young in a pediatric diabetes cohort: reduced health system costs and improved patient quality of life

2019

Conference Publication

Reviewing the quality of trials of biologic disease modifying antirheumatic drugs supporting PBS listing from 2006 – 2018

Meija, Abigail, McGuire, Treasure, van Driel, Mieke L. and Hollingworth, Samantha A. (2019). Reviewing the quality of trials of biologic disease modifying antirheumatic drugs supporting PBS listing from 2006 – 2018. Australasian Pharmaceutical Science Association Annual Conference, Melbourne, VIC Australia, 1-4 December 2019.

Reviewing the quality of trials of biologic disease modifying antirheumatic drugs supporting PBS listing from 2006 – 2018

2019

Conference Publication

Real-world consumers’ questions and concerns on DMARDs: a retrospective analysis of calls to a medicine call centre

El Masri, Hiba, Hollingworth, Samantha, van Driel, Mieke, Benham, Helen and McGuire, Treasure (2019). Real-world consumers’ questions and concerns on DMARDs: a retrospective analysis of calls to a medicine call centre. Australasian Pharmaceutical Science Association Annual Conference, Melbourne, VIC Australia, 1-4 December 2019.

Real-world consumers’ questions and concerns on DMARDs: a retrospective analysis of calls to a medicine call centre

2018

Journal Article

Medicine use during acute and chronic post-injury periods in whiplash injured individuals

Ritchie, Carrie, Hollingworth, Samantha A, Warren, Jacelle and Sterling, Michele (2018). Medicine use during acute and chronic post-injury periods in whiplash injured individuals. Pain, 160 (4), 1-851. doi: 10.1097/j.pain.0000000000001460

Medicine use during acute and chronic post-injury periods in whiplash injured individuals

2018

Journal Article

Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib

McGrath, Alexandria C., Sandhu, Geeta, Walpole, Euan, McCaffrey, Elizabeth and Hollingworth, Samantha A. (2018). Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib. Anti-Cancer Drugs, 29 (8), 786-790. doi: 10.1097/CAD.0000000000000640

Survival outcomes in patients with non-small-cell lung cancer treated with erlotinib

2018

Journal Article

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)

Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018). Psychopharmacology, 235 (7), 2193-2193. doi: 10.1007/s00213-018-4909-5

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014 (vol 235, pg 1915, 2018)

2018

Journal Article

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use

Pache, David M., Hollingworth, Samantha A., van Driel, Mieke L. and McGuire, Treasure M. (2018). Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use. Research in Social and Administrative Pharmacy, 15 (4), 440-447. doi: 10.1016/j.sapharm.2018.06.012

Does consumer medicines interest reflect medicines use? An Australian observational study comparing medicines call center queries with medicines use

2018

Journal Article

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

Adewumi, Adeleke D., Staatz, Christine E., Hollingworth, Samantha A., Connor, Jason P. and Alati, Rosa (2018). Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit. Drug Safety, 41 (11), 1-11. doi: 10.1007/s40264-018-0687-6

Prescription Opioid Fatalities: Examining Why the Healer Could be the Culprit

2018

Journal Article

Use of complementary and alternative medicines in people with depression and central obesity: findings from a Tai Chi and Qigong study

Liu, Xin, Hollingworth, Samantha, Williams, Gail, Martin, Jennifer, Kostner, Karam, Crompton, David, Xue, Charlie and Vitetta, Luis (2018). Use of complementary and alternative medicines in people with depression and central obesity: findings from a Tai Chi and Qigong study. Journal of Traditional Chinese Medical Sciences, 5 (2), 100-109. doi: 10.1016/j.jtcms.2017.09.006

Use of complementary and alternative medicines in people with depression and central obesity: findings from a Tai Chi and Qigong study

2018

Journal Article

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014

Hollingworth, Samantha A., Winckel, Karl, Saiepour, Nargess, Wheeler, Amanda J., Myles, Nicholas and Siskind, Dan (2018). Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014. Psychopharmacology, 235 (7), 1915-1921. doi: 10.1007/s00213-018-4881-0

Clozapine-related neutropenia, myocarditis and cardiomyopathy adverse event reports in Australia 1993-2014

2018

Journal Article

More needs to be spent on hepatitis C treatment, not less

Clark, Paul J., Muranushi, Chiho and Hollingworth, Samantha A. (2018). More needs to be spent on hepatitis C treatment, not less. Internal Medicine Journal, 48 (3), 364-366. doi: 10.1111/imj.13718

More needs to be spent on hepatitis C treatment, not less

2018

Journal Article

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

Adewumi, Adeleke D., Hollingworth, Samantha A., Maravilla, Joemer C., Connor, Jason P. and Alati, Rosa (2018). Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose. CNS Drugs, 32 (2), 101-116. doi: 10.1007/s40263-018-0499-3

Prescribed Dose of Opioids and Overdose: A Systematic Review and Meta-Analysis of Unintentional Prescription Opioid Overdose

2018

Conference Publication

Evaluating healthcare interventions using Interrupted time series analysis: an example from the Women’s Health Initiative study describing its impact on hormone therapy use in Australia

Natari, R., McGuire, T. M., Clavarino, A. M., Dingle, K. D. and Hollingworth, S. A. (2018). Evaluating healthcare interventions using Interrupted time series analysis: an example from the Women’s Health Initiative study describing its impact on hormone therapy use in Australia. Indonesia in an era of change Conference, Brisbane, QLD, Australia, 3-4 April 2018.

Evaluating healthcare interventions using Interrupted time series analysis: an example from the Women’s Health Initiative study describing its impact on hormone therapy use in Australia

2018

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial

Siskind, D., Mayfield, K., Winckel, K., Hollingworth, S. and Kisely, S. (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial. SHPA MM2019, Brisbane, Australia, 22-25 November 2019.

Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX): a pilot randomised controlled trial

2018

Conference Publication

Sustained impact of the Women’s Health Initiative study on hormone therapy use in Australia: an interrupted time series analysis

Natari, R., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Sustained impact of the Women’s Health Initiative study on hormone therapy use in Australia: an interrupted time series analysis. 27th Federation of Asian Pharmaceutical Associations Congress, Manila, Phillipines, 24-27 October 2018.

Sustained impact of the Women’s Health Initiative study on hormone therapy use in Australia: an interrupted time series analysis

2018

Conference Publication

Women’s Health Initiative study: its longitudinal impact on hormone and complementary therapy use for menopausal symptoms in Australia

Natari, R., Baker, P., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Women’s Health Initiative study: its longitudinal impact on hormone and complementary therapy use for menopausal symptoms in Australia. PSA18, Sydney, Australia, 27-29 July 2018.

Women’s Health Initiative study: its longitudinal impact on hormone and complementary therapy use for menopausal symptoms in Australia

2018

Conference Publication

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial

Siskind, Dan, Russell, Anthony, Gamble, Clare, Winckel, Karl, Hollingworth, Sam and Kisely, Steve (2018). Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial. 6th Biennial Conference of the Schizophrenia International Research Society (SIRS), Florence, Italy, 4-8 April 2018. Oxford, United Kingdom: Oxford University Press. doi: 10.1093/schbul/sby016.436

Treatment of clozapine-associated obesity and diabetes with exenatide (Codex) in adults with schizophrenia: a randomised controlled trial

2018

Conference Publication

Longitudinal impact of the Women’s Health Initiative study on hormone and complementary therapy used for menopausal symptoms in Australia

Natari, R., Baker, P., McGuire, T., Clavarino, A., Dingle, K. and Hollingworth, S. (2018). Longitudinal impact of the Women’s Health Initiative study on hormone and complementary therapy used for menopausal symptoms in Australia. National Medicines Symposium 2018, Canberra, ACT, Australia, 30 May - 1 June 2018.

Longitudinal impact of the Women’s Health Initiative study on hormone and complementary therapy used for menopausal symptoms in Australia

Funding

Past funding

  • 2021 - 2024
    Opioids and other prescription medicines use in people presenting to Queensland emergency departments for acute minor (non-admitted) Road Traffic Crash injury: a one year community follow-up study usi
    Metro South Hospital and Health Service
    Open grant
  • 2013 - 2014
    Utilisation review of Ezetimibe
    Department of Health and Ageing
    Open grant
  • 2012 - 2013
    Prescription opioid users in Australia- just who are they?
    UQ New Staff Research Start-Up Fund
    Open grant
  • 2010 - 2018
    NHMRC CRE: Improving quality and safety of health care delivery at the interface between primary and acute care sectors
    NHMRC Centres of Research Excellence
    Open grant

Supervision

Availability

Dr Sam Hollingworth is:
Not available for supervision

Supervision history

Current supervision

Completed supervision

Media

Enquiries

Contact Dr Sam Hollingworth directly for media enquiries about:

  • health services research
  • medicine use in populations
  • pharmacoepidemiology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au